Trinity Biotech (TRIB) announced that the Company welcomes the indicated intention of its largest investor and primary lender, Perceptive Advisors, to submit a proposal that, if implemented, would facilitate the conversion of a portion of the Company’s outstanding debt and other obligations into equity. The Company believes this strategic initiative represents a constructive step toward strengthening its balance sheet and that an equitization program, if successfully executed, could enhance the Company’s financial flexibility and support its ambitious growth objectives.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Amends Constitution and Credit Agreement Following AGM
- Trinity Biotech Announces AGM Results and Board Changes
- Trinity Biotech Releases 2024 Annual Report
- Trinity Biotech Regains Nasdaq Compliance as of September 2025
- Trinity Biotech regains compliance with Nasdaq listing requirements